Abstract
Pain is one of the most common symptoms in systemic sclerosis (SSc) patients, yet not considered in the assessment of disease severity. This study aimed to investigate the frequency of neuropathic pain (NP) and to evaluate its interference with the quality of life (QoL) in SSc patients. Diffuse and Limited SSc patients diagnosed by American College of Rheumatology 2013 criteria were included in the study. Pain was evaluated with Visual Analogue Scale (VAS); presence of NP was screened with The Leeds Assessment of Neuropathic Symptoms and Signs (LANNS) questionnaire; disease activity was evaluated with modified Medsger Severity Scale (MSS) and QoL with short-form 36 (SF-36). One hundred twenty patients were included in the study (mean age 53.64 ± 11.44 years, female/male 83.3–16.7%). Total pain frequency was found 69.2% and NP was 35.9% in the entire patient group. Pain was most frequently seen in wrist-hand (50.6%) and ankle-foot (43.4%) regions; albeit, NP rates were highest in face (94.4%), lower leg (87.5%), and hip-thigh (78.6%) regions. SF-36 scores were significantly lower in patients with NP than the patients without NP (P < 0.05). The most associated factors with NP were MSS score for muscle involvement and drug consumption of the patient. According to our results, high frequency of NP is seen in SSc patients, and NP is associated with low QoL. Differential diagnosis of NP is important to consider right treatment options and accurate management of pain in all rheumatologic diseases including SSc.
Similar content being viewed by others
References
Stisi S, Sarzi-Puttini P, Benucci M, Biasi G, Bellissimo S, Talotta R, Atzeni F (2014) Pain in systemic sclerosis. Reumatismo 66:44–47
Willems LM, Kwakkenbos L, Leite CC et al (2014) Frequency and impact of disease symptom experienced by patients with systemic sclerosis from five European countries. Clin Exp Rheumatol 32:88–93
Bagnato G, Cordova F, Sciortino D, Miceli G, Bruno A, Ferrera A, Sangari D, Coppolino G, Muscatello MRA, Pandolfo G, Zoccali RA, Roberts WN (2018) Association between cortisol levels and pain threshold in systemic sclerosis and major depression. Rheumatol Int 38:433–441
Perrot S, Dieudé P, Pérocheau D, Allanore Y (2013) Comparison of pain, pain burden, coping strategies, and attitudes between patients with systemic sclerosis and patients with rheumatoid arthritis: a cross-sectional study. Pain Med 14:1776–1785
Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, White B, Wigley FM (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275
Schieir O, Thombs BD, Hudson M, Boivin JF, Steele R, Bernatsky S, Hanley J, Baron M, Canadian Scleroderma Research Group (2010) Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res 62:409–417
Leroy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O, Ilie D, Rambeloarisoa J, Marjanovic Z, Cabane J, Sereni D, Pouchot J, Farge D (2006) Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford) 45:1298–1302
Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M (2007) Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol 34:1718–1726
Garcia-Larrea L (2014) The pathophysiology of neuropathic pain: critical review of models and mechanisms. In Raja SN, Sommer CL (eds) Pain 2014: refresher courses, 15 World Congress on pain Washington, DC: IASP Press pp 453–475
Lee YC, Lu B, Edwards RR, Wasan AD, Nassikas NJ, Clauw DJ, Solomon DH, Karlson EW (2013) The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum 65:59–68
Marchettini P, Lacerenza M, Mauri E, Marangoni C (2006) Painful peripheral neuropathies. Curr Neuropharmacol 4:175–181
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755
Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167
Bennett M (2001) The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92:147–157
Koc R, Erdemoglu AK (2010) Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire. Pain Med 11:1107–1114
Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A (1999) Kısa Form-36 (KF-36)‘nın Türkçe versiyonunun Güvenilirliği ve Geçerliliği. İlaç ve Tedavi Dergisi 12:102–106
Hinton PR, Brownlow C, McMurray I, Cozens B (2004) Using SPSS to analyse questionnaires: reliability. In: Hinton PR (ed) SPSS explained. East Sussex, UK, Routledge Inc, pp 363–364
Koop SM, ten Klooster PM, Vonkeman HE, Steunebrink LM, van de Laar MA (2015) Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis Res Ther 17:237
Meirinhos T, Aguiar R, Ambrósio C, Barcelos A (2014) Neuropathic pain in rheumatic diseases: a cross-sectional study. Ann Rheum Dis 73:A76
Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM (2013) Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: a comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res(Hoboken) 65:1291–1298
Unal-Cevik I, Sarioglu-Ay S, Evcik D (2010) A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. J Pain 11:1129–1135
Hallström H, Norrbrink C (2011) Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury? Pain 152:772–779
Avouac J, Walker U, Tyndall A et al (2012) Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 37:1488–1501
Randone SB, Guiducci S, Cerinic MM (2008) Musculoskeletal involvement in systemic sclerosis. Best Pract Res Clin Rheumatol 22:339–350
Fischoff DK, Sirois D (2000) Painful trigeminal neuropathy caused by severe mandibular resorption and nerve compression in a patient with systemic sclerosis: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:456–459
Teasdall RD, Frayha RA, Shulman LE (1980) Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore) 59:149–159
Mohyuddin A, Myers D, Guazzo E (2009) Bilateral trigeminal neuralgia associated with limited systemic sclerosis. J Clin Neurosci 16:708–710
Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede RD (2016) Neuropathic low back pain in clinical practice. Eur J Pain 20:861–873
Ordeberg G (2004) Characterization of joint pain in human OA. Novartis Found Symp 260:105–15; discussion 115–21, 277–279
Hochman JR, French MR, Bermingham SL, Hawker GA (2010) The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken) 62:1019–1023
Strange G, Nash P (2009) The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. Int J Rheum Dis 12:192–206
Demiral Y, Ergor G, Unal B, Semin S, Akvardar Y, Kıvırcık B, Alptekin K (2006) Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health 6:247
Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, Franceschini F, Cattaneo R (2005) Health-related quality of life measured by the short form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24:48–54
Almeida C, Almeida I, Vasconcelos C (2015) Quality of life in systemic sclerosis. Autoimmun Rev 14:1087–1096
van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH (2007) Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford) 46:872–876
Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 50:762–767
Fakata KL, Lipman AG (2003) Pharmacotherapy for pain in rheumatologic conditions: the neuropathic component. Curr Pain Headache Rep 7:197–205
Acknowledgements
We owe special thanks to Claire Brady for providing linguistic support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The local ethics committee has approved the research (June 10, 2016;54).
Disclosures
None.
Rights and permissions
About this article
Cite this article
Cuzdan, N., Turk, I., Sarpel, T. et al. Neuropathic pain: is it an underestimated symptom in systemic sclerosis?. Clin Rheumatol 37, 1845–1851 (2018). https://doi.org/10.1007/s10067-018-4107-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-018-4107-1